Has anyone dealt with do the heart benefits go away if i stop taking it??

BenResearch_OR ↑ said:

I'm 67 years old and want to share my perspective on cardiovascular risk as an older member of this community.

Genuinely useful, thank you. I had the facts and not the framework. Printing the relevant bit and taking it with me.

lisa_labSD said:

Anti-inflammatory mechanisms of GLP-1 agonists and cardiovascular risk: beyond weight loss, GLP-1R activation directly suppresses NF-κB signaling,…

Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history. Results were encouraging:

• NT-proBNP: 60 pg/mL (normal, cardiac function preserved)
• Lp(a): 60 nmol/L (genetic, unchanged — expected)
• ApoB: dropped from 145 to 85 mg/dL (excellent response)
• Coronary calcium score: 0 (unchanged from baseline — reassuring)

The ApoB reduction is particularly meaningful — it's considered the best single predictor of cardiovascular risk. GLP-1 therapy seems to improve this consistently.

CanadaChris said:

My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Metabolic syndrome resolution on cardiovascular risk: I went from meeting 3 of 5 diagnostic criteria to meeting ZERO after 11 months of treatment.

The 5 criteria (and my journey):

1. Waist circumference: 50" → 36" ✅ Resolved
2. Triglycerides: 222 → 102 ✅ Resolved
3. HDL: 34 → 54 ✅ Resolved
4. Blood pressure: 142/92 → 120/74 ✅ Resolved
5. Fasting glucose: 117 → 86 ✅ Resolved

Metabolic syndrome reversal is, in my view, the most medically significant outcome of GLP-1 therapy.

Moderator note: the sourcing question belongs in the vendor section and has been split out.